Texas Prostate Completes 100th TULSA Procedure; Volume Jumps 500% Under Medicare Model
Texas Prostate team led by Dr. James Cochran completed its 100th TULSA Procedure at Dallas Medical Center’s MRI suite, marking a key adoption milestone for Profound Medical’s technology. Following a shift from private pay to Medicare reimbursement, monthly TULSA volumes surged 500%, driving new enquiries across Texas.
1. Texas Prostate Hits 100 TULSA Procedures
Texas Prostate team led by Dr. James Cochran reached 100 TULSA procedures at Dallas Medical Center’s MRI suite, marking a key adoption milestone for Profound Medical’s TULSA-PRO system.
2. Medicare Model Spurs 500% Volume Increase
After transitioning from a private-pay model to Medicare reimbursement, procedure volume at Texas Prostate increased by 500%, fueled by growing enquiries from urologists across the Dallas-Fort Worth Metroplex and neighboring states.
3. Advantages of TULSA-PRO System
The TULSA-PRO system delivers robotically controlled directional ultrasound under continuous MRI thermography, enabling precise ablation with no blood loss, no overnight hospital stay, and reduced side effects such as urinary incontinence and erectile dysfunction.
4. Commercial Implications for Profound Medical
This commercial breakthrough highlights growing market penetration for Profound Medical and may drive future revenue growth as more urology centers adopt the Medicare-based model for prostate disease treatment.